| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |